statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Positive Outlook on Elevation Oncology: Anticipating EO-3021 Data Release Impact

In a report released today, Silvan Tuerkcan from JMP Securities reiterated a Buy rating on Elevation Oncology (ELEV Research Report), with a pric...

Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer

Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer Elevation Oncology Announces Planned Combination Strategy for...

Elevation Oncology to Present at the Citizens JMP Life Sciences Conference

Elevation Oncology to Present at the Citizens JMP Life Sciences Conference Elevation Oncology to Present at the Citizens JMP Life Sciences Conference PR Newswire BOSTON, May 7, 2024 BOSTON, May 7...

Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements

Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent...

Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024

Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024 Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at...

13 Hot Stocks to Invest in According to Wall Street Analysts

In this piece, we will take a look at the 13 hot stocks to invest in according to Wall Street analysts. If you want to skip our overview of the stock market and the latest news, then you can skip...

Elevation Oncology, Inc. (NASDAQ:ELEV) Sees Large Decline in Short Interest

Elevation Oncology, Inc. (NASDAQ:ELEV  Get Free Report) saw a significant decrease in short interest in February. As of February 29th, there was short interest totalling 3,610,000 shares, a...

JMP Securities Reiterates "Market Outperform" Rating for Elevation Oncology (NASDAQ:ELEV)

JMP Securities reissued their market outperform rating on shares of Elevation Oncology (NASDAQ:ELEV  Free Report) in a research report report published on Thursday, Benzinga reports. JMP...

Analysts Offer Insights on Healthcare Companies: Adaptimmune Therapeutics (ADAP), Elevation Oncology (ELEV) and AC Immune SA (ACIU)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Adaptimmune Therapeutics (ADAP Research Report), Elevation Oncology...

Wedbush Raises Elevation Oncology (NASDAQ:ELEV) Price Target to $8.00

Elevation Oncology (NASDAQ:ELEV  Free Report) had its price objective lifted by Wedbush from $5.00 to $8.00 in a research note issued to investors on Thursday, Benzinga reports. They currently...

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.

Volume	192,685.00
52-Wk High	$5.83
52-Wk Low	$0.363

ELEV Elevation Oncology Inc

About

Feed

News

Fundamentals